Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets

Cellular and Molecular Gastroenterology and Hepatology - United States
doi 10.1016/j.jcmgh.2018.01.020
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search